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An Inactivating Point Mutation in the Inhibitory
Wedge of CD45 Causes Lymphoproliferation
and Autoimmunity
Kung et al., 2000). At least one function of CD45 is to
dephosphorylate the C-terminal site of negative regula-
tory tyrosine phosphorylation within src-family kinases
(Mustelin et al., 1989; Ostergaard et al., 1989; Shiroo et
al., 1992; McFarland et al., 1993; Sieh et al., 1993; Seavitt
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CD45 exists as several isoforms due to alternative
splicing of exons 4, 5, and 6 within the extracellular
domain (Trowbridge and Thomas, 1994). The alterna-
tively spliced exons encode multiple sites of O-linkedSummary
glycosylation, so that the extracellular domain of the
high molecular weight isoforms (CD45RA1) differs inA model has been proposed for the regulation of CD45,
structure and overall charge from the low molecularand by homology other RPTPs, in which dimerization
weight isoform (CD45R0) that lacks these three exonsinhibits phosphatase activity through symmetrical in-
(McCall et al., 1992). In T cells, the alternative splicingteractions between an inhibitory structural wedge and
of CD45 is regulated so that naı¨ve T cells predominantlythe catalytic site. Here, we report the phenotype of mice
express CD45RA1 isoforms and switch to expressionwith a single point mutation, glutamate 613 to arginine,
of CD45R0 upon activation (Akbar et al., 1988; Birkelandthat inactivates the inhibitory wedge of CD45. The CD45
et al., 1989). These observations suggest that the extra-E613R mutation causes polyclonal lymphocyte activa-
cellular domain regulates CD45 function, perhaps bytion leading to lymphoproliferation and severe auto-
binding to a ligand or by mediating dimerization.immune nephritis with autoantibody production, result-
Dimeric forms of the RPTPs CD45 and RPTPa haveing in death. Both homozygotes and heterozygotes
been identified. In the case of CD45, homodimers havedevelop pathology, indicating genetic dominance of
been detected biochemically through chemical cross-CD45 E613R. The dramatic phenotype of CD45 E613R
linking and sucrose gradient centrifugation (Takeda etmice demonstrates the in vivo importance of negative
al., 1992). Additionally, a recombinant protein consistingregulation of CD45 by dimerization, supporting the
of the membrane proximal region and phosphatase do-model for regulation of CD45, and RPTPs in general.
main 1 of CD45 was found to exist primarily as dimers
(Felberg and Johnson, 1998). Dimers of RPTPa haveIntroduction
been detected by biochemical “trapping” using an engi-
neered disulfide linkage, and through chemical cross-The receptor-like transmembrane protein tyrosine phos-
linking (Jiang et al., 1999; Jiang et al., 2000). However,phatases (RPTPs) constitute a large family of widely
the mechanism by which dimerization of these mole-expressed signal transduction molecules (Neel and
cules is regulated is not currently known.
Tonks, 1997; Schaapveld et al., 1997). However, the
The consequences of dimerization on RPTP function
physiological roles and direct biochemical substrates
were tested with a chimeric molecule consisting of the
of most RPTPs are poorly characterized. extracellular and transmembrane domains of the EGF
CD45 is an RPTP expressed on all nucleated hemato- receptor fused to the cytoplasmic domain of CD45
poietic cells, where it is required for signal transduction (EGFR-CD45) (Desai et al., 1993). EGFR-CD45 restored
through antigen receptors (Trowbridge and Thomas, TCR-mediated signal transduction in a CD45-deficient T
1994; Weiss and Littman, 1994; Neel, 1997). The require- cell line. Strikingly, EGF-induced dimerization of EGFR-
ment for CD45 has been demonstrated by studies of (1) CD45 inhibited TCR-mediated signal transduction. This
CD45-deficient T and B cell lines (Pingel and Thomas, inhibition depended on dimerization of the CD45 cyto-
1989; Koretzky et al., 1990; Justement et al., 1991; plasmic domain, suggesting that CD45 is negatively reg-
Weaver et al., 1991), which fail to respond to antigen ulated by dimerization.
receptor stimulation, (2) CD45-deficient mice, which A potential molecular explanation for this negative
show profound blocks in both T and B cell development regulation was provided by the crystal structure of the
and function (Kishihara et al., 1993; Byth et al., 1996), membrane-proximal region and PTP domain 1 of RPTPa
and (3) CD45-deficient humans, who have a severe com- (Bilwes et al., 1996). This protein fragment forms a sym-
bined immunodeficiency (SCID) phenotype similar to metrical dimer in which the catalytic site of one molecule
that observed in CD45-deficient mice (Cale et al., 1997; is blocked by specific contacts with a structural wedge
from the membrane-proximal region of the other. Amino
acid residues forming this wedge, including two acidic# To whom correspondence should be addressed (e-mail: aweiss@
medicine.ucsf.edu). residues at the tip, are conserved within the membrane-
Cell
1060
proximal regions of RPTPs, including CD45 (Bilwes et
al., 1996). Moreover, sequences within this region of
CD45 are conserved phylogenetically from shark to hu-
man, potentially indicating an important conserved
structure and function. These observations suggest a
general model for the regulation of RPTPs in which di-
merization inhibits phosphatase activity, and conse-
quently function, through symmetrical interactions be-
tween the catalytic site and the structural wedge
containing the acidic residues (Weiss and Schlessinger,
1998).
To test this model, we mutated a glutamic acid resi-
Figure 1. Identification of Full-Length CD45 Homodimersdue in the tip of the putative inhibitory wedge of CD45,
293 cells were transiently transfected with empty expression vectorin the context of EGFR-CD45, and used this mutant chi-
(Vec) or expression constructs for CD45 with a linker either con-mera to reconstitute TCR-mediated signaling in CD45-
taining a cysteine residue (Cys) or not (WT). Whole-cell lysates were
deficient T cells (Majeti et al., 1998). Treatment of these prepared and CD45 was detected under reducing and non-reducing
cells with EGF, however, failed to inhibit TCR-mediated conditions by immunoblotting with antibody to CD45. CD45 con-
signal transduction, providing evidence of a critical role taining either linker is present as monomers under reducing condi-
tions (left). Under non-reducing conditions, CD45 containing thefor the inhibitory wedge in negative regulation of CD45
cysteine-linker forms dimers and monomers (right). Data are repre-function by dimerization. Studies with RPTPa have also
sentative of 3 separate analyses.indicated an essential role for the structural wedge in
the negative regulation of RPTPa activity by dimerization
(Jiang et al., 1999). Cells in which dimeric RPTPa was
introduced into the extracellular domain of CD45 adja-“trapped” with an engineered disulfide linkage exhibited
cent to the transmembrane domain, so that if they form,increased phosphorylation of Y527 of Src, the substrate
homodimers of CD45 would be stabilized through anfor RPTPa, demonstrating dimerization-induced inhibi-
intermolecular disulfide bond. This strategy has beention of RPTPa activity; significantly, mutations in the
employed to demonstrate ligand-dependent dimeriza-structural wedge restored activity to RPTPa dimers.
tion of the EGFR (Sorokin et al., 1994), and has alsoThese experiments supporting the model for dimeriza-
been utilized to detect constitutive homodimers oftion-mediated negative regulation of RPTPs by the in-
RPTPa (Jiang et al., 1999). 293 cells were transientlyhibitory wedge were conducted ex vivo using modified
transfected with empty expression vector (Vec) or ex-RPTPs. One prediction derived from these studies is
pression constructs for CD45 with a linker either con-that mutation of the inhibitory structural wedge in vivo
taining a cysteine residue (Cys) or not (WT) (Figure 1).will lead to inappropriate RPTP activation under normal
Western blotting with anti-CD45 antibody of whole-celldimerizing conditions. In the case of CD45, such dysreg-
lysates demonstrated that CD45 containing either linkerulated activity would cause inappropriate src-kinase ac-
is present as a monomer under reducing conditions (Fig-tivation, with potentially pathological consequences.
ure 1, left). However, under non-reducing conditions,Here, we report the phenotype of “knockin” mice in
CD45 containing the cysteine-linker forms dimers aswhich a single critical glutamate in the inhibitory struc-
well as monomers (Figure 1, right). Thus, homodimerstural wedge of CD45 has been mutated to arginine (CD45
of full-length CD45 can be detected and may be subjectE613R). CD45 E613R mice appear normal during the
to negative regulation by the inhibitory wedge.first few months of life; however, they subsequently de-
velop a lymphoproliferative syndrome with apparent
polyclonal T and B lymphocyte activation, and severe Generation of CD45 E613R Knockin Mice
autoimmune nephritis with autoantibody production. As Previous studies with the EGFR-CD45 chimera indicated
a result, these mice die prematurely. The dramatic phe- that mutation of glutamate 624 to arginine within the
notype of CD45 E613R mice demonstrates the in vivo inhibitory wedge of human CD45 eliminates negative
importance of negative regulation of CD45 by dimeriza- regulation of CD45 by dimerization (Majeti et al., 1998).
tion, supporting the model for regulation of CD45, and To study the role of dimerization-mediated inhibition in
RPTPs in general. vivo, the homologous residue in the mouse, glutamate
613, was mutated to arginine (E613R) through a gene-
targeting knockin strategy. Using a genomic fragmentResults
containing glutamate 613 of murine CD45, the E613R
mutation was introduced, and a loxP-flanked neomycin-Identification of Full-Length CD45 Homodimers
The experiments supporting the model for dimerization- resistance cassette was inserted into the downstream
intron (Figure 2A). Transfection of this construct intomediated negative regulation of CD45 by the inhibitory
wedge were conducted with a chimeric EGFR-CD45 129-derived ES cells targeted the endogenous CD45
locus by homologous recombination at a frequency ofmolecule (Desai et al., 1993; Majeti et al., 1998). Homodi-
meric forms of full-length CD45 have been detected 3 out of 1200 clones (Figure 2B). Germline transmission
was achieved after microinjection of 2 of these clones.through chemical cross-linking and sucrose gradient
centrifugation of cellular lysates (Takeda et al., 1992). The two mutant mouse lines were subsequently bred to
b-actin Cre transgenic mice to eliminate the neomycin-To further explore the dimerization potential of CD45, a
short linker sequence containing a cysteine residue was resistance cassette (Figures 2A and 2B). An additional
Autoimmunity in CD45 Inhibitory Wedge Mutant Mice
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Figure 2. Generation of CD45E613R“Knockin”
Mice
(A) Schematics of the genomic, E613R tar-
geted, and E613R recombined alleles of
CD45. The E613R mutation was engineered
along with a PvuI site into exon 18. A novel
HindIII site was introduced with a loxP-
flanked neomycin-resistance cassette into
the downstream intron at an EcoRI site.
Germline targeted mice were bred to b-actin
Cre transgenic mice eliminating the neomy-
cin-resistance cassette, while retaining the
HindIII site. Fragment sizes generated by di-
gestion with HindIII are indicated, along with
the probes used for Southern blot analysis.
(B) Southern blot analysis of DNA prepared
from ES cell lines (left) and mouse tails (right).
DNA was digested with HindIII and the blot
was probed with the 39 probe. Expected frag-
ments are indicated to the right. Genotypes
are indicated above each lane. Analysis with
a neomycin probe identified a single band
indicating integration of the targeting con-
struct into a single site only (data not shown).
(C) Equivalent surface expression of CD45 on
thymocytes, lymph node cells, and spleno-
cytes. Cells from wild-type (plain), heterozy-
gote (dotted), and homozygote (bold) tissues
were stained with a pan-specific anti-CD45
antibody and analyzed by flow cytometry. Un-
stained cells are indicated with the shaded
histogram. The plain, dotted, and bold lines
superimpose in each case.
cross to C57BL/6 eliminated the b-actin Cre transgene, and homozygous mutant mice showed indistinguishable
levels of CD45 on the surface of thymocytes, lymphresulting in mice carrying only the E613R mutation and
an insertion of approximately 140 nucleotides into the node cells, and splenocytes (Figure 2C).
downstream intron. The data presented here are derived
from mice on this mixed background; similar results Normal Lymphocyte Development and Activation
in 4-Week Old CD45 E613R Micewere obtained with both independently-derived knockin
lines. The presence of the E613R mutation in CD45 T cell development in CD45 E613R mice was assessed
by analyzing thymocytes from 4-week old wild-type, het-mRNA was verified by sequencing of RT-PCR products
(data not shown). These mice will be referred to as CD45 erozygous, and homozygous mutant mice. Total thymic
cellularity was similar between these mice, as was theE613R mice.
CD45 E613R heterozygous mice were interbred to CD4/CD8 surface profile of the thymocytes (Figure 3A,
top). Analysis of thymocytes from CD45 E613R micegenerate homozygous mice. Both homozygotes and
heterozygotes were born at Mendelian frequencies and carrying an MHC class I–restricted TCR transgene rec-
ognizing the male-specific HY antigen indicated no dif-appeared normal at birth. To assess any disruption of
CD45 expression caused by the E613R mutation, the ferences compared to wild-type HY TCR transgenic
mice in thymic cellularity or CD4/CD8 profile for bothsurface level of CD45 was analyzed by flow cytometry
using a pan-CD45 antibody. Wild-type, heterozygous, females and males (data not shown), suggesting no ma-
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Lymphoproliferation with Polyclonal T and B Cell
Activation in CD45 E613R Mice
Young CD45 E613R mice appeared normal, but as they
aged, mutant mice developed progressive lymphade-
nopathy and splenomegaly. The degree of tissue en-
largement observed varied from mild (not shown) to
severe (Figures 4A and 4B). Generalized lymphadenopa-
thy was observed in severe cases; however, in mild
cases, lymphadenopathy was often confined to the cer-
vical and submandibular lymph nodes. Enlarged spleens
of CD45 E613R mice weighed between 3 to 10 times
more than spleens from wild-type mice. No enlargement
of the thymus was noted. Lymphadenopathy was not
observed in mice younger than 15 weeks nor in wild-
type mice of any age (n 5 13); however, 15% of heterozy-
gotes (n 5 24) and 70% of homozygotes (n 5 20) older
than 15 weeks developed lymphadenopathy, with ap-
proximately half being severe.
Histological analysis of enlarged lymph nodes from
CD45 E613R mice demonstrated intact follicular archi-
tecture with expansion in all areas including cortical
primary follicles, interfollicular T cell zones, and medul-
lary sinuses (Figure 4D). Higher power examination dem-
onstrated the normal mixed cellular composition of the
interfollicular and medullary areas in wild-type lymph
nodes (Figure 4E); however, a marked increase in plas-
macytoid cells within the background of normal mixed
cells was observed in enlarged lymph nodes from CD45
E613R mice (Figure 4F). This histological picture charac-Figure 3. Normal Lymphocyte Development and Activation in
terizes a lymphoproliferative syndrome.4-Week Old CD45 E613R Mice
Histological analysis of enlarged spleens from CD45(A) Normal lymphocyte development. Cells from thymus and spleen
of 4-week old mice were stained with anti-CD4 and anti-CD8 (thy- E613R mice demonstrated expansion of both the white
mus) or anti-IgD and anti-IgM (spleen) and analyzed by flow cytome- pulp and red pulp (Figure 4H). The histological charac-
try. The percentages of cells within defined regions are indicated. teristics of the lymphoid tissue of the splenic white pulp
Genotypes are indicated above the panels. The decreased number were similar to that of the lymph nodes (data not shown).
of IgMlo/IgDhi splenic B cells in homozygous mutant mice was not
Expansion of the splenic red pulp was accompaniedconsistently observed. Data are representative of 3 separate
by a marked increase in extramedullary hematopoiesisanalyses.
(B) Normal lymphocyte activation. Cells from lymph nodes and (EMH) in the spleen. Some degree of EMH is normal in
spleens of 4-week old mice were stained with anti-CD3 and anti- the mouse, as indicated by the occasional megakaryo-
CD69 (lymph node) or anti-CD19 and anti-CD69 (spleen) and ana- cyte detected in wild-type spleens (Figure 4I). However,
lyzed by flow cytometry. The percentage of CD31 or CD191 cells this contrasts with the extensive EMH in the enlarged
staining with CD69 is indicated. Genotypes are indicated above the
spleens from mutant mice. Along with numerous mega-panels. Data are representative of 3 separate analyses.
karyocytes, islands of erythropoiesis and granulopoiesis
were observed throughout the enlarged spleens (Figure
4J). Analysis of the bone marrow indicated abnormally
increased granulopoiesis and a paucity of erythropoie-jor effect of CD45 E613R on positive and negative selec-
sis; however, the complete blood counts of these micetion events in the thymus.
were normal (data not shown).B cell development in CD45 E613R mice was as-
Single-cell suspensions were prepared from lymphsessed by analyzing surface expression of IgM and IgD
nodes of CD45 E613R mice with mild and severe lymph-on splenocytes from 4-week old mice. No differences
adenopathy; data representative of 5 separate analysesin the B cell IgM/IgD surface profile were observed in
are presented (Figure 5). The total number of cells inspleens from wild-type, heterozygous, and homozygous
these lymph nodes was found to be increased 2- tomutant mice (Figure 3A, bottom). Thus, T and B lympho-
8-fold over wild type; additionally, an increase in largecyte development in CD45 E613R mice appears to pro-
cells was noted based on the forward scatter profileceed normally.
(data not shown). Both control and lymphoproliferativeIn order to assess the activation state of lymphocytes
nodes contained similar percentages of CD31 T cellsin 4-week old CD45 E613R mice, surface expression of
and CD191 B cells, with approximately 50%–75% T cellsthe lymphocyte activation marker CD69 was analyzed
(Figure 5A). Analysis of expression of a panel of Vb TCRon CD31 lymph node T cells and CD191 splenic B cells.
gene segments on T cells failed to reveal any differencesNo differences in the percentage of CD691 T cells or B
between control and lymphoproliferative nodes; simi-cells were detected (Figure 3B). These data indicate
larly, no difference in the proportion of l light chain–that there is no increase in the frequency of activated
lymphocytes in 4-week old CD45 E613R mice. expressing B cells was noted (data not shown). These
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data suggest that polyclonal T and B cell expansion is
responsible for the lymphadenopathy.
Both T and B cells in lymphoproliferative nodes were
found to be activated as determined by surface expres-
sion of CD69. On T cells, CD69 expression was in-
creased from 21% in wild type to 34% in mild lymphade-
nopathy, and 57% in severe lymphadenopathy; CD69
expression was increased on B cells from 26% in wild
type to 62% and 70%, in mild and severe lymphadenop-
athy, respectively (Figures 5B and 5C). T cells were fur-
ther examined for expression of CD25, CD44, CD62L,
CD45RB, CD40L, CTLA-4, Fas, and FasL. No increase in
CD25 expression was noted in either mild or severe cases
of lymphadenopathy (data not shown). CD44 expres-
sion was increased only in mice with severe lymphade-
nopathy (Figure 5D). Decreased expression of CD62L
and CD45RB was noted in severely affected mice (Fig-
ures 5E and 5F); however, mildly affected mice exhibited
a decrease only in CD62L. These surface expression
patterns identify activated T cells in CD45 E613R lymph-
oproliferative nodes, with indications of more extensive
activation in mice with severe lymphadenopathy.
No differences in surface expression of CD40L, Fas,
or FasL were noted between T cells from wild-type and
CD45 E613R mice; furthermore, no difference in the
number of CD41CD251CTLA-41 regulatory T cells was
detected (data not shown). Expression of the costimula-
tory molecules B7-1 and B7-2 was similar on both B cells
and Mac11 cells; additionally, there was no increase in
the percentage of CD51IgM1 B cells in either the spleen
or peritoneal cavity of CD45 E613R lymphoproliferative
mice (data not shown). Single-cell suspensions of sple-
nocytes had a similar surface phenotype as lymph node
cells in lymphoproliferative CD45 E613R mice (data not
shown).
Elevated Serum IgA and IL-10 Transcripts
in CD45 E613R Mice
Serum immunoglobulin levels were measured to assess
global immune system activation in CD45 E613R mice.
Serum IgM and total IgG levels were similar in wild-type,
heterozygous, and homozygous mutant mice (Figure
6A). Analysis of individual IgG isotypes revealed a 12-
Figure 4. Lymphadenopathy and Splenomegaly in CD45 E613R fold increase in serum IgG2a levels in heterozygous and
Mice homozygous CD45 E613R mice; all other IgG isotypes
(A and B) Lymph nodes (A) and spleens (B) from an age-matched were equivalent (Figure 6A). The most striking finding was
wild-type mouse and CD45 E613R homozygous mutant mouse with a 35-fold elevated serum IgA in homozygous mutant mice,
severe lymphadenopathy and splenomegaly. Scale bars represent with a 7-fold increase in heterozygotes (Figure 6A).
0.5 cm.
IgA class switching and production is commonly stim-(C–J) Lymph node (C–F) and spleen (G–J) histology. Panels on the
ulated by TGFb; however, no increase in total TGFb wasleft (C, E, G, and I) are derived from age-matched wild-type mice
detected in serum from these mice (data not shown).while those on the right (D, F, H, and J) are from CD45 E613R
homozygous mutant mice with severe lymphadenopathy and sple- Expression of a panel of cytokines, including IL-4, 5, 10,
nomegaly. (C and D) Intact follicular architecture in enlarged CD45 13, 15, 9, 2, 6, and IFN-g was assayed using RNA from
E613R lymph nodes. Expansion is observed in all areas: cortical lymph node and spleen of lymphoproliferative CD45
follicles, interfollicular T cell zones, and medullary sinuses. (E and
E613R mice. Quantitative RNase protection indicatedF) Normal mixed cellular composition in the interfollicular and medul-
an increase in the levels of IL-10 and IFN-g transcripts,lary areas of wild-type mice and increased plasmacytoid cells with
but not of the other cytokines (Figure 6B).extensive dark gray cytoplasm (arrows) in a background of normal
mixed cells in mutant mice. A single enlarged plasmacytoid cell is
shown in the inset (F). (G and H) Expansion of red pulp and white
pulp in enlarged CD45 E613R spleens. Note the increased cellularity
of the red pulp in mutant mice. Fissures in (G) are an artifact of karyocytes and islands of erythropoiesis and granulopoiesis
tissue processing. (I and J) Extensive extramedullary hematopoiesis (arrows) are observed in mutant spleens. All panels were stained
in enlarged CD45 E613R spleens. An occasional megakaryocyte with hematoxylin and eosin (H&E). (C, D, G, and H) Scale bars repre-
(“M”) is observed in wild-type spleens; however, numerous mega- sent 100 mM. (E, F, I, and J) Scale bars represent 5 mM.
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Autoimmune Lupus Nephritis with Autoantibody
Production in CD45 E613R Mice
In the course of analyzing mice presenting with lymph-
adenopathy, it was observed that their kidneys ap-
peared grossly pale and shrunken. Histological analysis
of kidney sections derived from these mice demon-
strated interstitial nephritis characterized by the pres-
ence of numerous mononuclear cells, tubular epithelial
cell injury, interstitial fibrosis, and edema (Figure 7B).
Some dilated tubules contained proteinaceous casts.
The glomeruli exhibited increased cellularity, thickened
capillary loops, and an increase in mesangial matrix; in
addition, karyorrhexis was noted in a segmental pattern
(Figure 7D). Positive silver staining in mesangial areas
indicated the presence of increased matrix (Figure 7F).
Silver staining of the glomerular basement membrane
showed “double contours” with pink staining material
between the two contours consistent with the presence
of protein deposits (Figure 7F). These findings were not
observed in control mice (Figures 7A, 7C, and 7E).
Electron microscopy was performed to further analyze
the glomeruli of CD45 E613R mice. Numerous subendo-
thelial and mesangial deposits were identified, along
with widespread epithelial cell foot process effacement
(Figure 7H). Wild-type mice showed some patchy re-
gions of foot process coarsening and small mesangial
deposits, but no subendothelial deposits (Figure 7G).
Together, these light and electron microscopy findings
support a pathological diagnosis of diffuse membrano-
proliferative glomerulonephritis in CD45 E613R mice.
In an attempt to identify the protein deposits within
the glomeruli of CD45 E613R mice, kidney sections from
wild-type and mutant mice were stained with FITC-
labeled anti-mouse IgG and analyzed by immunofluo-
rescence microscopy. The glomeruli of wild-type mice
did not stain for IgG (Figure 7I). In contrast, the mutant
glomeruli exhibited diffuse granular staining of capillary
loops (Figure 7J), establishing that the deposits seen on
both light and electron microscopy represent immune
complexes. Although the serum IgA levels in the mutant
mice were elevated (Figure 6A), no IgA deposits were
found in their glomeruli (data not shown).
Immune complex–mediated glomerulonephritis as de-
Figure 5. Lymphocyte Activation in CD45 E613R Micescribed here is also observed in the human autoimmune
disease systemic lupus erythematosus (SLE), suggesting Lymph node cells from a wild-type mouse (left), a CD45 E613R
homozygote with mild lymphadenopathy (center), and a CD45an autoimmune etiology in CD45 E613R mice. In SLE,
E613R heterozygote with severe lymphadenopathy (right) werenumerous autoantibodies are produced; while no single
stained with antibodies specific for the indicated cell surface mark-autoantibody is diagnostic for SLE, antibodies directed
ers and analyzed by flow cytometry. (A) The percentages of cellsagainst double-stranded DNA (anti-dsDNA) are specific
within defined regions are indicated. (B, D, E, and F) The percentage
for SLE. To assess the development of autoimmunity in of CD31 cells staining with the indicated marker is noted. (C) The
CD45 E613R mice, serum was collected and screened percentage of CD191 cells staining with CD69 is indicated. Data are
for the presence of anti-dsDNA antibodies. No wild- representative of 5 separate analyses.
type mice had positive titers for anti-dsDNA antibodies;
however, 25% of heterozygous and 63% of homozygous
mised renal function may develop in these mice. Renalmutant mice were positive with similar average titers
damage was confirmed by the discovery of significant(Figure 8A). Positive titers were detected in homozy-
proteinuria in several older mutant mice. In order togotes as early as 9 weeks of age and in heterozygotes
characterize the kinetics and severity of renal disease,at 18 weeks. Thus, CD45 E613R mice spontaneously
proteinuria in a cohort of young mice was followed (Fig-develop autoimmunity characterized by the production
ure 8B). Proteinuria, greater than 30 mg/dl, was ob-of anti-dsDNA autoantibodies.
served in homozygous mutant mice as early as 6 weeks
of age. At 22 weeks, 54% of homozygotes had exhibitedProteinuria, Renal Failure, and Reduced Survival
abnormal proteinuria, while none was detected in het-in CD45 E613R Mice
erozygous or wild-type mice. However, by 26 weeks ofThe pathological identification of autoimmune glomeru-
lonephritis in CD45 E613R mice suggested that compro- age 33% of heterozygotes, but 0% of wild-type mice,
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Figure 6. Evaluation of Serum Immunoglobulin Levels and Cytokine Expression in CD45 E613R Mice
(A) Elevated serum IgG2a and IgGA in CD45 E613R mice. All levels were measured by enzyme-linked immunosorbent assay (ELISA). Average
age of mice (in weeks) was as follows: 1/1 16.9 (n 5 4), 1/m 16.1 (n 5 6), and m/m 13.5 (n 5 10).
(B) Increased IL-10 and IFN-g transcripts in lymphoproliferative CD45 E613R mice. Expression of a panel of cytokines, including IL-4, 5, 10,
13, 15, 9, 2, 6, and IFN-g was determined using RNA from lymph nodes and spleens of lymphoproliferative CD45 E613R mice by RNase
protection. Protected fragments corresponding to IL-10, IFN-g, and the controls L32 and GAPDH are indicated. Data are representative of 4
control-matched mice.
had developed proteinuria. Proteinuria was observed in tory dimerizing conditions, resulting in inappropriate
lymphocyte activation with pathological consequences.both female and male mutant mice at a similar fre-
quency. Finally, some CD45 E613R mice developed oli- Here, we report the phenotype of mice with a single
point mutation, glutamate 613 to arginine, engineeredguria and subsequently died, suggesting renal failure
leading to death. into the putative inhibitory wedge of CD45. Glutamate
613 was selected for mutagenesis based on in vitroDuring necropsy analysis of some CD45 E613R mice
observed to be extremely thin and lethargic, they experiments, indicating that this residue is critical for
negative regulation of CD45 by dimerization. The CD45were noted to have massively enlarged stomachs full
of undigested food. Histological analysis of the stomach E613R mutation has no overt effect on lymphocyte de-
velopment, but causes a lymphoproliferative syndromeand gastrointestinal tract, including gut-associated
lymphoid tissue, identified no abnormalities (data not with apparent polyclonal T and B lymphocyte activation,
gastric retention, and severe autoimmune nephritis withshown). To date, no examination of gastric structure or
function has been found to be abnormal in these mice; autoantibody production. As a result, these mice die
prematurely. The dramatic phenotype of CD45 E613Rhowever, this phenotype is still being investigated. Strik-
ingly, this gastric retention was observed only in female knockin mice supports our model for negative regulation
of CD45 by dimerization.CD45 E613R mice, all of which had significant renal
disease. No abnormalities were noted in heart, lung, Mechanistic consideration of the model predicts that
dimerization of CD45 will result in inappropriate CD45pancreas, liver, skin, or peripheral joints in any mutant
mice (data not shown). activation not only in mice homozygous for CD45 E613R,
but also in mice heterozygous for this mutation. CD45CD45 E613R heterozygous and homozygous mice de-
velop multiple pathologies including lymphoprolifera- dimers in heterozygotes are expected to possess half
the CD45 activity found in homozygotes, potentiallytion, autoimmune nephritis leading to renal failure, and
gastric retention leading to malnutrition. As a conse- leading to delayed kinetics or a less severe phenotype.
This is indeed the case, as we have observed delayedquence, these mice die prematurely (Figure 8C). The
first homozygote death occurred at 15 weeks while the onset of identical pathology in heterozygotes as seen
in homozygotes, including premature death. These ob-first heterozygote death was not observed until 31
weeks. By 50 weeks of age, no wild-type, but 25% of servations indicate that CD45 E613R functions as a ge-
netically dominant mutation.heterozygous and 43% of homozygous mutant mice
had died.
In Which Cells Does Regulation of CD45
by Dimerization Occur?Discussion
T and B lymphocyte activation are observed in CD45
E613R mice (Figure 5), indicating that both cell typesWe have proposed a model for the regulation of the
RPTP CD45 in which dimerization inhibits CD45 through are affected by the mutation. However, the regulation
of CD45 by dimerization, and thus the primary effect ofthe symmetrical interactions of the structural wedge of
one molecule with the catalytic site of the other (Weiss the E613R mutation, may be restricted to one of these
cell types, with activation of the other a secondary event.and Schlessinger, 1998). One prediction of this model
is that mutation of the structural wedge in vivo will result In vitro proliferative responses of purified lymph node
T cells and splenic B cells from CD45 E613R mice werein inappropriate CD45 activation under normally inhibi-
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Figure 7. Lupus Nephritis in CD45 E613R
Mice
Panels on the left (A, C, E, G, and I) are derived
from age-matched wild-type mice while
those on the right (B, D, F, H, and J) are from
CD45 E613R homozygous mice. (A and B)
Normal renal architecture in wild-type mice
and patchy interstitial nephritis (arrow) char-
acterized by chronic inflammation, tubular in-
jury, and interstitial nephritis in mutant mice.
(H&E) (C and D) Normocellular glomeruli in
wild-type mice and hypercellular glomerulus
with karyorrhexis and mesangial matrix ex-
pansion in mutant mice. Note also the inter-
stitial inflammation and tubular injury. (H&E)
(E and F) Slight matrix increase in glomeruli of
wild-type mice; mutant mice show a greater
degree of matrix increase and double con-
tours (arrow) in capillary loops. Note also
pink-staining deposits within the capillary
loops. (PAS-Jones silver) (G and H) Electron
micrographs showing a single capillary loop.
Normal glomerular basement membrane in
wild-type mice without subendothelial de-
posits; foot processes are generally pre-
served although some coarsening is present.
In contrast, mutant mice have numerous su-
bendothelial deposits (“D”) and widespread
foot process effacement; additionally, note
reduplication of glomerular basement mem-
brane (arrow), which represents the double
contour seen on silver stain. (Uranyl ace-
tate 1 lead citrate) (I and J) Immunofluores-
cence of kidney sections stained with FITC-
labeled anti-mouse IgG. No staining is noted
in wild-type mice while granular loop staining
is noted in mutant mice. Scale bars: (A, B, I,
and J), 10 mM; (C, D, E, and F), 2 mM; (G and
H), 1 mM.
indistinguishable from those of wild-type mice (data not the cell type subject to regulation by CD45 dimerization,
including non-lymphocytes.shown), and so failed to identify the affected cell type.
Furthermore, we have found no evidence for activation
of any src-kinase, including Lck, from CD45 E613R mice, Regulation of CD45 Dimerization
using an antiserum that specifically detects activated Dimeric forms of CD45 have been detected (Figure 1),
src-kinases (data not shown). Since we are uncertain indicating that it is possible for CD45 to form dimers.
which of the polyclonal cells might be subject to the One potential means of regulating CD45 dimerization is
effects of CD45 dimerization and cannot synchronously through interaction with a ligand, or perhaps differential
modulate CD45 dimerization, it is not too surprising that interaction of a ligand with the various isoforms of CD45.
we could not detect changes in src-kinase activity. How- To date, numerous attempts have failed to definitively
ever, when CD45 function is synchronously modulated identify any ligand for CD45, though they do not rule
by dimerization of the EGFR-CD45 chimera, inhibition out its existence. Another possible mechanism for regu-
of known functions of Lck is evident (Majeti et al., 1998). lating CD45 dimerization is differential spontaneous ho-
modimerization of CD45 isoforms. The identification ofWe are currently using genetic approaches to identify
Autoimmunity in CD45 Inhibitory Wedge Mutant Mice
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Figure 8. Autoantibodies, Renal Disease,
and Reduced Survival in CD45 E613R Mice
(A) Autoantibody production in CD45 E613R
mice: anti-dsDNA antibody titers. Serum was
prepared from mice of various ages at the
time of sacrificing and anti-dsDNA antibody
titers were determined by ELISA. The titer
was considered positive if greater than 1/128.
NA, not applicable.
(B) Kinetics of proteinuria in CD45 E613R
mice. Cumulative incidence of proteinuria
was measured weekly with urine dipsticks
and considered to be positive if greater than
30 mg/dl (1 on a scale from 0 to 1111).
Percent of mice that had positive proteinuria,
defined as 2 or more positive tests by the
indicated time, is shown. Cohort included: 1/1
(n 5 11), 1/m (n 5 12), and m/m (n 5 13).
(C) Reduced survival of CD45 E613R mice.
The multiple pathologies of CD45 E613R mice
lead to premature death. Cohort included:
1/1 (n 5 11), 1/m (n 5 12), and m/m
(n 5 14).
homodimers of CD45 stabilized through an engineered that multiple RPTPs are negatively regulated by dimer-
ization, in a manner dependent on the structural wedge.disulfide linkage in the absence of exogenously added
proteins (Figure 1), suggests that CD45 may spontane- The structural wedge was first identified in the dimeric
crystal structure of the membrane proximal region andously homodimerize. The alternatively spliced exons of
CD45 encode multiple sites of O-linked glycosylation phosphatase domain 1 (D1) of RPTPa; sequence align-
ment indicates conservation in the analogous region ofso that the extracellular domain of CD45RA1 isoforms
carries a strong negative charge, which could form an a number of RPTPs (Bilwes et al., 1996). Notably, in
the other RPTP crystal structures available, RPTPm D1electrostatic repulsive barrier to homodimerization. On
the other hand, CD45R0 does not contain these glyco- (Hoffmann et al., 1997) and the cytoplasmic domain of
LAR (Nam et al., 1999), the structural wedge is alsosylation sites, and thus may homodimerize more effi-
ciently. observed. These results suggest that the wedge is struc-
turally conserved within the family of RPTPs and mayWhatever the mechanism that regulates CD45 dimer-
ization, we hypothesize that CD45R0 dimerizes substan- also have a conserved function.
However, the symmetrical inhibitory interaction be-tially and, consequently, is subject to negative regulation
by the inhibitory wedge. We propose a model in which tween the wedge and the catalytic site detected in the
dimeric crystal structure of RPTPa D1 was not observedactivated T cells, over the course of several days follow-
ing stimulation, switch from expression of CD45RA1 iso- in the structures of RPTPm D1 or LAR. In fact, only
monomers were detected in both of these structures. Onforms to CD45R0; CD45R0 then forms inactive dimers
which contribute to the cessation of the primary T cell this basis, these authors have suggested that inhibitory
dimers of RPTPm and LAR may not form. However, asresponse.
crystal structures represent only selected conforma-
tions of a molecule, these results do not rule out dimer-Regulation of Receptor Protein Tyrosine Phosphatases
ization as a regulatory mechanism for RPTPm and LAR.Negative regulation of RPTP function by dimerization
In the context of the full-length molecules, dimerizationhas been suggested for additional RPTPs. RPTPa has
mediated by the extracellular domain could alter thebeen demonstrated to form constitutive homodimers
conformation of the cytoplasmic domain, favoring inter-using the disulfide trapping approach employed here as
actions between the structural wedge and catalyticwell as by chemical cross-linking (Jiang et al., 1999,
sites. Functional studies will be necessary to determine2000). Furthermore, dimerization was shown to inhibit
if these molecules dimerize and if they are negativelyRPTPa phosphatase activity through the inhibitory
regulated by dimerization.wedge (Jiang et al., 1999). Drosophila mutants lacking
the RPTP, PTP69D, are not viable due to unknown devel-
opmental defects (Desai et al., 1996); intriguingly, Autoimmunity in CD45 E613R Mice
Autoimmune lupus nephritis with autoantibody produc-PTP69D with a point mutation in the wedge is unable
to rescue this defect, raising the possibility that this tion is observed in CD45 E613R mice. T cell responses
required for the initiation of this autoimmune responseRPTP is normally regulated by the structural wedge dur-
ing development (Garrity et al., 1999). Finally, binding are most likely directed against endogenous or food
antigens. This possibility is being explored by fixing theof the soluble ligand pleitrophin to RPTPb/z results in
inhibition of RPTPb/z phosphatase activity, suggesting TCR repertoire with MHC class I or class II–restricted
TCR transgenes, which are predicted to prevent auto-that ligand-induced dimerization negatively regulates
RPTPb/z function (Meng et al., 2000). Our experiments immune disease; subsequent immunization with the TCR-
specific peptide may then initiate disease. Spontaneouswith CD45, in conjunction with these reports, suggest
Cell
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following oligos: (1) gCD45mut5: tggtcagggaccttttatc, (2) gCD45mut3:autoimmunity in CD45 E613R mice has been limited to
tcactttgggtaaatgggg, (3) gCD45E613R: attgccgatcggggcagactg,anti-dsDNA antibody production and lupus nephritis.
and (4) complement of gCD45E613R, and was confirmed by nucleo-However, these mice may have a generally increased
tide sequencing. This mutagenesis scheme introduced a novel PvuI
susceptibility to autoimmunity which could be revealed site into exon 18, along with the E613R mutation. A lox P-flanked
by immunization with autoantigens. neomycin-resistance cassette from pL2-neo-2 (Gu et al., 1993) was
inserted into the EcoRI site in the downstream intron. An HSV-Our findings have significant implications regarding
thymidine kinase cassette from pBS/MC1-TK (Mansour et al., 1988)the genetics of human SLE. Several autoimmune mouse
was cloned into the nonhomologous region of the targeting con-models of SLE exist, including complex polygenic disor-
struct at a NotI site. The whole construct was linearized with SacII,ders (NZB/NZW) as well as single gene disorders (MRL/
prior to transfection into 129-derived ES cells (Ramı´rez-Solis et al.,
lpr, gld), which result in lupus-like disease when present 1993).
in the background of an autoimmune-prone strain (An-
drews et al., 1978; Roths et al., 1984; Steinberg et al., Generation of CD45 E613R “Knockin” Mice
Transfected ES cells were processed and screened by standard1984). However, to our knowledge, CD45 E613R is the
techniques (Ramı´rez-Solis et al., 1993). Homologous recombinationfirst single genetic lesion that functions dominantly in
was detected in 3 out of 1200 clones by Southern blot genotyping.causing lupus. Although human SLE has been widely
Two of these clones were used to generate chimeric male mice by
speculated to result from complex multigene factors, it blastocyst injection (Hogan, 1994), which were then bred to C57BL/6
is possible that this disease is a collection of rare simple females (The Jackson Laboratory) to identify germline transmitters.
Mendelian disorders as well as polygenic disorders. The Heterozygous progeny from both lines were subsequently bred to
b-actin Cre transgenic mice (Lewandoski and Martin, 1997). To iden-ability of CD45 E613R to function as a dominant allele
tify offspring with germline excision of the lox P–flanked neomycin-causing an SLE-like syndrome in mice suggests that
resistance cassette, these mice were bred to C57BL/6 and progenysome cases of human SLE could result from alleles that
were screened for both elimination of the b-actin Cre transgene
disrupt the dimer-induced inhibition of CD45 function. and the recombined CD45 E613R allele. Such mice represent true
Studies of human SLE patients are in progress to ad- heterozygotes and were interbred to generate homozygous CD45
dress this; however, it is noteworthy that 3 genome anal- E613R mice. All mice were housed in the specific-pathogen free
barrier facility at UCSF and were provided food and water ad libitum.yses have identified a polymorphic allele adjacent to the
CD45 locus that is weakly associated with SLE (Tsao et
Southern Blot Analysis and Genotypingal., 1997; Gaffney et al., 1998; Harley et al., 1998; Moser
Tail DNA was prepared (Hogan, 1994), digested with HindIII, sepa-et al., 1998).
rated on a 0.8% analytical agarose gel, transferred to Hybond N
membrane (Amersham), and hybridized with 32P-labeled probe (Re-
Conclusion diprime II from Amersham), followed by washes and autoradiogra-
phy. Hybridization with the 39 probe (KpnI to HindIII 300 bp fragment)
to the wild-type CD45 allele produces a 7.8 kb fragment and to theWe have shown here that a single point mutation in the
E613R allele produces a 4.5 kb fragment.inhibitory structural wedge of CD45 is sufficient to cause
lymphocyte activation, leading to lymphoproliferation
Flow Cytometry
and spontaneous autoimmunity in mice. The dramatic Single cell suspensions were prepared from thymus, lymph node,
phenotype of CD45 E613R mice demonstrates the in and spleen. 106 cells were stained for each sample and analyzed
on a FACSCalibur (Becton Dickinson). Antibodies were used at 1/100vivo importance of negative regulation of CD45 by di-
or 1/200 and were directed against: pan-CD45-FITC, IgD-FITC, IgM-merization. These results strongly support a model for
PE, CD3-biotin, CD19-PE, CD69-FITC, CD44-FITC (all from Phar-the regulation of CD45, and by homology other RPTPs,
mingen), and CD62L-PE, CD45RB-biotin, CD4-PE, CD8-TC, strep-in which dimerization inhibits phosphatase activity, and
tavidin-tricolor (all from Caltag).
consequently, function, through symmetrical interac-
tions between the inhibitory structural wedge and the Tissue Processing and Histology
catalytic site. For hematoxylin and eosin or PAS-Jones staining, tissue fragments
were fixed in 10% formalin for a minimum of 24 hr and were subse-
quently embedded in paraffin, sectioned, and stained using stan-Experimental Procedures
dard techniques. For immunofluorescence, tissue fragments were
embedded in OCT, flash-frozen in liquid nitrogen, and sectionedCD45 Dimerization Assay
with a cryostat. Sections were stained with sheep anti-mouse IgG-A short amino acid linker consisting of either GAGAGAGA (wt) or
FITC (The Binding Site) at 1/50 dilution. For electron microscopy,GAGAGCGA (Cys) was introduced into the cDNA of murine
tissue fragments were fixed in glutaraldehyde for a minimum of 24CD45RABC after asparagine 550 using standard recombinant DNA
hr; electron micrographs were prepared using standard procedures.techniques. These modified CD45 proteins were expressed in HEK
293 cells using the pCDEF3 expression vector by transient transfec-
tion using calcium phosphate. After 48 hr, the cells were harvested Serum Processing and ELISA
and lysed in standard lysis buffer 1 10 mM iodoacetamide (Majeti Serum was prepared from blood harvested by cardiac puncture at
et al., 1998). Whole-cell lysates were mixed with 23 SDS sample the time of sacrificing. Serum immunoglobulin levels were deter-
buffer either with (reducing) or without (nonreducing) 0.5% b-ME, mined by enzyme-linked immunosorbent assay (ELISA) using an
and analyzed by SDS-PAGE and Western blotting as described immunoglobulin isotyping kit (Southern Biotech) and standards
previously (Majeti et al., 1998). Antibody to murine CD45 (#476) was (Southern Biotech) as per the manufacturer’s protocol. IgG antibod-
a generous gift from M. Thomas, St. Louis. ies to dsDNA in sera from individual mice were measured by ELISA
as described (Wofsy and Seaman, 1985).
Preparation of Targeting Construct
A P1 clone containing exon 18 of murine genomic CD45 was ob- RNase Protection Assay
Single-cell suspensions of lymph node cells and splenocytes weretained by PCR screening (Genome Systems). A 6.5 kb BamHI to
KpnI fragment suitable for the targeting construct was cloned into solubilized in RNAzol B (Tel-Test) and RNA was prepared following
the manufacturer’s protocol. Cytokine transcript levels were deter-pBluescript KS (Stratagene). Oligonucleotide-directed mutagenesis
of glutamate 613 to arginine was accomplished by PCR using the mined by RNase protection assay using the Riboquant kit (Phar-
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mingen) with the mCK-1 primer set as per the manufacturer’s pro- The genetics of human systemic lupus erythematosus. Curr. Opin.
Immunol. 10, 690–696.tocol.
Hoffmann, K.M., Tonks, N.K., and Barford, D. (1997). The crystal
Proteinuria Analysis structure of domain 1 of receptor protein-tyrosine phosphatase mu.
A cohort of mice was selected for weekly analysis of proteinuria. J. Biol. Chem. 272, 27505–27508.
Urine was obtained from each mouse by manually applying pressure Hogan, B. (1994). Manipulating the Mouse Embryo: A Laboratory
on the bladder. The urine was applied to a colorimetric dipstick Manual, 2nd Edition (Plainview, NY: Cold Spring Harbor Laboratory
(Bayer) and read on a scale from 0 to 1111. Press).
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